Search

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at [email protected].

… Monday, January 11, 2016 Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule

Women and ethnic minorities are underrepresented in science. Memorial Sloan Kettering is working to change that.

… Friday, November 2, 2018 Edwin Kamau (NYU) and Laura González-Fajardo (University of Connecticut) Graduate students Edwin Kamau (NYU) and Laura González-Fajardo (University of Connecticut) Patrick Cherubin (University of Central Florida) and Michael Riley II (University of Florida) Graduate students

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.

… Thursday, June 6, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek, MD , gastrointestinal oncologist, section

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report. MSK has been consistently ranked among the top two cancer centers in the country for over 30 years.

… Tuesday, July 27, 2021 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report in its annual Best Hospitals listing. MSK has been consistently ranked among the top two cancer centers in the country for over 30

Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.

… Monday, November 23, 2020 Summary Genetic mutations that give cancers a metabolic boost may also leave them vulnerable to drugs that promote a particular form of cell death, Sloan Kettering Institute researchers have found. If there is a silver lining in cancer’s chaotic biology, it’s that the same traits

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.

… Wednesday, October 1, 2025 Memorial Sloan Kettering Cancer Center (MSK) presented new research on a range of important topics at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO), held September 27 to October 1 in San Francisco. The presentations included two clinical trials

Get an inside look into the life of a student from the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.

… Tuesday, November 23, 2021 As a student at the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences, you will join the laboratory of one of more than 130 scientists from Memorial Sloan Kettering Cancer Center with expertise in cancer biology, genomics, immunology, structural biology,

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

… Wednesday, August 19, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer

Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.

… Monday, November 7, 2022 Highlights MACHETE is a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models. Using MACHETE, researchers found that a prominent deletion often eliminates a cluster of interferon genes — leading to poorer outcomes in mouse models of

In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation.

… Wednesday, June 9, 2004 Summary In recognition of his contributions in basic science related to cancer research, Sloan Kettering Institute Director Thomas J. Kelly has been awarded the 2004 Alfred P. Sloan, Jr. Prize by the General Motors Cancer Research Foundation. In recognition of his contributions